Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate post-abortion injection of compound norethisterone enanthate: menstrual pattern and dysmenorrhea improvement
ChiCTR2100055053Phase 4Recruiting
- Sponsor
- Guangzhou Women and Children's Medical Center
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of norethisterone enanthate in dysmenorrhea, sponsored by Guangzhou Women and Children's Medical Center. Primary endpoints: Menstrual pattern and Improvement of dysmenorrhea. Started Jan 2022; status: recruiting.
02
Drugs
norethisterone enanthate
03
Conditions
dysmenorrhea
Beyond the preview
Go deeper on ChiCTR2100055053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100055053.